DEVICE GUIDE > Hybrid Vascular Grafts

Company Name Product Name Materials Used Nitinol Reinforced Section Diameter (mm) Nitinol Reinforced Section Length (cm) Vascular Graft Section Diameter (mm) Vascular Graft Section Length (cm) Introducer Size (F) Recommended Guidewire (inch) US FDA Indicated Use
Gore & Associates Gore Hybrid Vascular Graft Nitinol/ePTFE 6, 7, 8, 9 5, 10 6 50 11–14 peel­away for OTW (not available for open surgical) 0.035 for OTW (not available for open surgical) Intended for use as vascular prosthesis for replacement or bypass of diseased vessels in patients with occlusive or aneurysmal diseases, in trauma patients requiring vascular replacement, for dialysis access, or for other vascular procedures
Merit Medical Systems, Inc. Hero Graft Nitinol, silicone, tantalum, ePTFE, PTFE, barium sulfate, and titanium 5 (ID) 40 (customizable length) Graft: 6 (ID); titanium connector: 6–5 taper (ID) 53 20 peelaway for OTW 0.035 for OTW Indicated for end-stage renal disease patients on hemodialysis who have exhausted all other access options; see instructions for use for full indication, contraindication, and caution statements; Rx only
Merit Medical Systems, Inc. SuperHero Nitinol, silicone, tantalum, barium sulfate, titanium 5 (ID) 40 (customizable length) 0.86 cm (adapter clamp region length), 5.715 cm (adapter clamp region with support seal length) 20 (peelaway for OTW) 0.035 (for OTW, stiff) Indicated for end-stage renal disease patients on hemodialysis who have exhausted all other access options; see instructions for use for full indication, contraindication, and caution statements; Rx only

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.